Filing Flows › Comparisons › RMTI vs AYTU
Rockwell Medical vs Aytu Biopharma: RMTI and AYTU compared
Rockwell Medical is the larger company: $17.8M of revenue in its latest quarter (Q2 2026) against $16.1M for Aytu Biopharma (Q4 FY26). Rockwell Medical is growing faster (+11% against +6% a year earlier). Aytu Biopharma is more profitable, with an operating margin of -4.8% against -6.0%.
Where the money goes: RMTI and AYTU
Rockwell Medical (RMTI) · Q2 2026
Rockwell Medical, Q2 2026: revenue $17.8M (+11% year over year), operating margin -6.0%, net loss $1.2M, operating cash flow $2.1M. The chart follows the revenue to costs, profit and cash.
Aytu Biopharma (AYTU) · Q4 FY26
Aytu Biopharma, Q4 FY26: revenue $16.1M (+6% year over year), operating margin -4.8%, net loss $15K, operating cash flow $4.4M. The chart follows the revenue to costs, profit and cash.
| Rockwell Medical (RMTI) | Aytu Biopharma (AYTU) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q4 FY26 |
| Revenue | $17.8M | $16.1M |
| Revenue growth, Y/Y | +11% | +6% |
| Operating margin | -6.0% | -4.8% |
| Net earnings | −$1.2M | −$15K |
| Net margin | -6.6% | -0.1% |
| Operating cash flow | $2.1M | $4.4M |
| Free cash flow | $1.5M | $4.4M |
Questions
Which is bigger, Rockwell Medical or Aytu Biopharma?
Rockwell Medical is the larger company: $17.8M of revenue in its latest quarter (Q2 2026) against $16.1M for Aytu Biopharma (Q4 FY26).
Is Rockwell Medical or Aytu Biopharma growing faster?
Rockwell Medical is growing faster (+11% against +6% a year earlier).
Which is more profitable, Rockwell Medical or Aytu Biopharma?
Aytu Biopharma is more profitable, with an operating margin of -4.8% against -6.0%.
More: Rockwell Medical earnings · how Rockwell Medical makes money · Aytu Biopharma earnings · how Aytu Biopharma makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-K filed Sep 22, 2026). Fiscal quarters can end on different dates. Not investment advice.